There were no adverse gatherings or modifications from baseline in serologic research and important symptoms in any of your individuals. The procedure's ache-relieving consequences have been confirmed by standard, 12-7 days follow-ups, confirming the security and usefulness of BTX-A on chronic ON and suggesting that this technique is an effective,